StockNow
Calendar
Log in
U.S. Markets

Boston Scientific (BSX) Q3 2026 (USD): adj. EPS 0.73 (exp. 0.72), Revenue 5.14bln (exp. 5.06bln). Current FY adj. EPS 3.16-3.18 (exp. 3.22)

ORIGINAL · NewsquawkBoston Scientific (BSX) Q3 2026 (USD): adj. EPS 0.73 (exp. 0.72), Revenue 5.14bln (exp. 5.06bln). Current FY adj. EPS 3.16-3.18 (exp. 3.22)
StockNow breaking-news AI analysis

Boston Scientific’s Q3 adjusted EPS and revenue exceeded stated expectations; current FY adjusted EPS guidance is below the stated expectation.

1 stocks
BSXBoston Scientific Corp.$42.30Current price

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
Geopolitics

Ukrainian President Zelensky says Ukraine will not attack Russian ships carrying diesel for the US

Politics

Reports of a Yemeni attack targeting Saudi forces in Aden, Sabereen reports

U.S. Markets

Phillips 66 (PSX) Q3 2026 (USD): Adj. EPS 14.08 (exp. 11.73)

PSX